Good scientific practice of using worldwide post-marketing surveillance data to ensure safety with HAALI BDDE cross-linked hyaluronic acid fillers

Good scientific practice of using worldwide post-marketing surveillance data to ensure safety with HAALI BDDE cross-linked hyaluronic acid fillers

Background: Aliaxin fillers (HAALI), produced by IBSA Farmaceutici Italia SrL (Italy), are biodegradable, non-pyrogenic, 1,4-butanediol diglycidyl ether cross-linked hyaluronic acid (HA) hydrogels. The formulations are tailored for different clinical indications, ensuring precise and natural outcome...

Full description

Saved in:
Bibliographic Details
Main Authors: Hema Sundaram, Beatriz Molina, Editta Buttura da Prato, Gabriel Siquier-Dameto, Michela Zazzaron, Clara Cigni, Franco Grimolizzi
Format: Article
Language:English
Published: BioExcel Publishing Ltd 2024-12-01
Series:Drugs in Context
Subjects:
bdde cross-linked dermal filler
filler complications
hyaluronic acid
injectable safety
post-marketing surveillance
safety
Online Access:https://www.drugsincontext.com/good-scientific-practice-of-using-worldwide-post-marketing-surveillance-data-to-ensure-safety-with-haali-bdde-cross-linked-hyaluronic-acid-fillers/
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.drugsincontext.com/good-scientific-practice-of-using-worldwide-post-marketing-surveillance-data-to-ensure-safety-with-haali-bdde-cross-linked-hyaluronic-acid-fillers/

Similar Items